Using data from the European Organization for Research and Treatment of Cancer trial 30904, Emil Scosyrev, PhD, and colleagues at the University of Rochester Medical Center studied 258 patients who were randomized to undergo RN and 254 were randomized to undergo NSS.
The mean serum creatinine level after surgery was 1.411 mg/dL in RN patients and 1.153 in NSS, a significant difference of 0.258 mg/dL. Over 15 years of follow-up (median 6.7 years for serum creatinine), researcher found an estimated average rate of change of -0.008 mg/dL per year with RN and 0.004 mg/dL per year with NSS, a significant difference between the treatment arms.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.